Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect

Intravitreal ranibizumab is a first‐line therapy for neovascular age‐related macular degeneration (nAMD), but there is a need to optimize patient outcomes while minimizing treatment burden. Here, we developed an indirect response, nonlinear, mixed effects model of disease progression and drug effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulyukov, Zufar, Weber, Sebastian, Pigeolet, Etienne, Clemens, Andreas, Lehr, Thorsten, Racine, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202467/
https://www.ncbi.nlm.nih.gov/pubmed/30043524
http://dx.doi.org/10.1002/psp4.12322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202467/
https://www.ncbi.nlm.nih.gov/pubmed/30043524
http://dx.doi.org/10.1002/psp4.12322

Ejemplares similares